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Abstract
Background
Epicardial adipose tissue (EAT) has been shown to be a non-invasive marker that predicts
the progression of cardiovascular disease (CVD). It has been reported that the EAT volume
is increased in patients with chronic obstructive pulmonary disease (COPD). However, little
is known about which phenotypes of COPD are associated with increased EAT.
Methods
One hundred and eighty smokers who were referred to the clinic were consecutively
enrolled. A chest CT was used for the quantification of the emphysematous lesions, airway
lesions, and EAT. These lesions were assessed as the percentage of low attenuation vol-
ume (LAV%), the square root of airway wall area of a hypothetical airway with an internal
perimeter of 10 mm (
p
Aaw at Pi10) and the EAT area, respectively. The same measure-
ments were made on 225 Vietnamese COPD patients to replicate the results.
Results
Twenty-six of the referred patients did not have COPD, while 105 were diagnosed as having
COPD based on a FEV1/FVC<0.70. The EAT area was significantly associated with age,
BMI, FEV1 (%predicted), FEV1/FVC, self-reported hypertension, self-reported CVD, statin
use, LAV%, and
p
Aaw at Pi10 in COPD patients. The multiple regression analyses showed
that only BMI, self-reported CVD and
p
Aaw at Pi10 were independently associated with the
EAT area (R2 = 0.51, p<0.0001). These results were replicated in the Vietnamese
population.
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Conclusions
The EAT area is independently associated with airway wall thickness. Because EAT is also
an independent predictor of CVD risk, these data suggest a mechanistic link between the
airway predominant form of COPD and CVD.
Introduction
Cardiovascular disease (CVD) is one of the major causes of death in patients with chronic
obstructive pulmonary disease (COPD) [1]. There is considerable evidence that COPD and
CVD frequently coexist [2], and each condition affects the prognosis for the other [3]. CVD is
the second most common cause of death (after lung cancer) in smokers with mild to moderate
airway obstruction [4] and accounts for 27% of the deaths in COPD patients [5]. Therefore,
non-invasive markers, which can identify COPD patients at high risk for future CVD, are
important.
Epicardial adipose tissue (EAT), which accumulates around the heart between the myocar-
dium and the pericardium, has been shown to be a non-invasive marker for the development
of CVD [6]. EAT is considered to play a key role in the pathogenesis of coronary atherosclero-
sis. It was reported that EAT was associated with CVD risk in the general population [7]. A
report from the Multi-Ethnic Study of Atherosclerosis (MESA) indicated that the EAT volume
observed by a chest CT could be a predictor of the occurrence of CVD [6]. Further, Zagaceta
and colleagues have suggested that the volume of the EAT was higher in COPD patients than
in non-COPD patients [8].
We have previously shown that the measurements of airway disease and emphysema
assessed by CT are independently associated with aspects of the pathophysiology in COPD [9,
10]. Using these indices, we have also shown that COPD patients can be divided into four phe-
notypes: an airway-dominant phenotype, an emphysema-dominant phenotype, a mixed phe-
notype (airway and emphysema), and a normal CT phenotype [11].
However, little is known regarding different risks for CVD among these phenotypes or
whether biomarkers of CVD risk, such as the EAT, are more commonly associated with a spe-
cific COPD type. The aim of this study was to evaluate the relationship between the CT pheno-
type and the EAT volume in COPD patients.
Materials and Methods
Study Population
One hundred and eighty patients who visited the respiratory medicine outpatient clinic of the
Shiga University of Medical Science Hospital fromMay 2011 to May 2014 were consecutively
enrolled in this study. The details of the inclusion and exclusion criteria and the demographic
and clinical data for this study are described in S1 Appendix. As shown in Fig 1, 131 subjects
from the initial 180 former and current smokers remained in the final analysis. The study was
approved by the Ethics Committee of the Shiga University of Medical Science. All participants
agreed to participate in the study and provided written informed consents.
Pulmonary function tests
Spirometry was performed 15 minutes after inhalation of 20 μg of procaterol using a FUDAC-
771 spirometer (Fukuda Denshi, Tokyo, Japan) according to the recommendations of the ATS
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(American Thoracic Society)/ERS (European Respiratory Society) [12]. The predicted values
for spirometry were calculated in accordance with the guidelines of the Japanese Respiratory
Society [13].
CT Scans
Chest CT scans were performed using a 320-detector row CT scanner, Aquilion ONE1
(Toshiba Medical Systems, Tochigi, Japan). The inspiratory CT images were obtained in the
supine position after inhalation of 20 μg of procaterol. The CT images were reconstructed with
1.0 mm slice thickness and 0.5 mm intervals using the FC03 algorithm.
Quantification of emphysematous and airway lesions
All CT images were analyzed using the Apollo1 software (VIDA diagnostics, Coralville, IA,
USA) (http://www.vidadiagnostics.com) [14]. Emphysematous lesions were assessed as the
percentage of low attenuation volume (LAV%): less than -950 Hounsfield Unit (HU) [14]. The
airway wall thickness was assessed by measuring the square root of the airway wall area of a
hypothetical airway with an internal perimeter of 10 mm (
p
Aaw at Pi10) as reported previ-
ously [15].
Quantification of EAT
The EAT area at the origin of the left main coronary artery level, which was strongly associated
with total EAT volume [16], was measured by manually tracing the pericardium using ImageJ
software (Ver.1.47, National Institutes of Health, Bethesda, Maryland, USA) [17]. An image
setting was set as follows: window width -230 to -30 HU and window level -130 HU [16], to
Fig 1. Disposition of Subjects.
doi:10.1371/journal.pone.0148794.g001
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identify the pixels corresponding to the adipose tissue. The reproducibility of the intra- and
inter-observer measurements of EAT area in randomly selected 100 subjects were fairly well by
Bland-Altman analyses (data not shown).
Measurement of subcutaneous fat area
The subcutaneous fat area (SFA) at the level of the bottom of the right shoulder blade, which
was associated with abdominal visceral fat [11], was calculated using ImageJ software
(Ver.1.47) [17].
Coronary artery calcium score
The coronary artery calcium (CAC) scores were evaluated using the Agatston method [18] and
are shown in S2 Appendix. The reproducibility of the intra- and inter-observer measurements
of CAC scores in randomly selected 20 subjects were very well by Bland-Altman analyses (data
not shown).
Vietnamese COPD patients
Two hundred and twenty-five Vietnamese COPD patients were investigated in this study. The
details of the patient characteristics and the methodology for the CT measurements are
described in a previous report and are included in S3 Appendix [19]. The protocol for this
study was approved by the Biomedical Ethics Committee of University Medical Center in Ho
Chi Minh City. Written informed consent was obtained from all Vietnamese subjects.
Statistical analysis
The statistical analyses were carried out using the JMP software ver. 11 (SAS Institute, Cary,
NC, USA). The results for continuous variables are shown as the mean ± standard deviation
(SD). The Wilcoxon Rank-Sum test was used to compare groups. Spearman’s rank correlation
coefficient was used to evaluate the relationships between the EAT area, SFA and the CT
parameters. Bland-Altman analysis was performed to evaluate the reproducibility for the EAT
area and CAC scores. A p value less than 0.05 was considered significant.
Results
Subject characteristics
Twenty-six non-COPD smokers and 105 COPD patients were enrolled in this study. The char-
acteristics of the subjects are summarized in Table 1. The COPD patients were older, but there
was no significant difference in the BMI between the two groups. By definition, the pulmonary
function tests in the COPD patients showed substantially obstructed lung function. As
expected, the MRC dyspnea scale was significantly higher in COPD patients. The frequency of
self-reported CVD was significantly higher in the COPD patients (p = 0.049), but the frequen-
cies of hypertension and diabetes mellitus (DM) were not different between the two groups.
There were no significant differences in the oral corticosteroid and the statin use between the
two groups.
Quantitative analyses of emphysematous and airway wall lesions on
chest CTs
As shown in Table 2, both the LAV% and
p
Aaw at Pi10 were significantly higher in the
COPD patients than in the non-COPD smokers. In the COPD patients, the LAV% was
Epicardial Fat and Airway Lesion in COPD
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significantly correlated with the carbon monoxide diffusing capacity (DLCO/VA) (ρ = -0.626, p
=<0.0001) and the BMI (ρ = -0.373, p =<0.0001), and the
p
Aaw at Pi10 was significantly
correlated with the BMI (ρ = 0.201, p = 0.039) (Table 3).
Quantitative analyses of adipose tissue in chest CTs
The EAT area was significantly higher in the COPD group (Table 2). On the other hand, the
SFA showed no significant difference between the two groups.
Table 1. Subject characteristics.
non-COPD (n = 26) COPD (n = 105) p value
Age (years) 67.0 ± 9.01 73.1 ± 7.51 0.003
Male (%) 92.3 92.4 0.990
BMI (kg/m2) 23.0 ± 3.25 23.1 ± 2.76 0.738
Current smoker (%) 38.5 19.1 0.035
Pack-Years 47.5 ± 28.0 61.2 ± 31.4 0.012
MRC dyspnea scale* 1.16 ± 1.25 1.81 ± 1.23 0.022
FVC % predicted (%) 100.5 ± 14.7 101.0 ± 18.0 0.716
FEV1% predicted (%) 91.6 ± 12.8 66.9 ± 22.3 <0.0001
FEV1/FVC (%) 74.3 ± 3.49 52.1 ± 12.8 <0.0001
DLCO / VA (mL/min/mmHg/L)* 3.73 ± 1.02 2.69 ± 0.98 <0.0001
Self-reported hypertension (%) 34.6 37.1 0.130
Self-reported DM (%) 15.4 20.0 0.118
Self-reported CVD (%) 3.85 14.3 0.049
Oral corticosteroid use (%) 0.0 6.1 0.196
Statin use (%) 19.2 21.9 0.766
The data are presented as the mean ± standard deviation or %.
BMI, body mass index; MRC, Medical Research Council; FVC, forced vital capacity; FEV1, forced expiratory volume in 1 s; DLCO, carbon monoxide
diffusing capacity; DM, diabetes mellitus; CVD, cardiovascular disease.
* COPD (n = 103)
doi:10.1371/journal.pone.0148794.t001
Table 2. Comparison of the CT-measured parameters between the non-COPD and COPD groups.
non-COPD (n = 26) COPD (n = 105) p value
LAV% (%) 3.90 ± 4.48 12.5 ± 11.6 <0.0001p
Aaw at Pi10 (mm) 3.70 ± 0.08 3.75 ± 0.08 0.012
EAT area (cm2) 10.9 ± 7.69 13.1 ± 6.07 0.038
EAT area / BMI 0.45 ± 0.26 0.55 ± 0.22 0.030
SFA (cm2)* 76.0 ± 39.0 79.3 ± 34.8 0.684
CAC score** 1771 ± 3750 1428 ± 2704 0.796
CAC score >400 (%) ** 46.2 45.6 0.962
The data are presented as the mean ± standard deviation or %.
LAV%, percentage of low attenuation volume;
p
Aaw at Pi10 (mm), square root of airway wall area of a hypothetical airway with an internal perimeter of 10
mm; EAT, epicardial adipose tissue; SFA, subcutaneous fat area; CAC, coronary artery calcium.
* non-COPD (n = 23) COPD (n = 88)
** COPD (n = 103)
doi:10.1371/journal.pone.0148794.t002
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In the COPD patients, the EAT area was positively associated with the airway wall thickness,p
Aaw at Pi10 (ρ = 0.379, p =<0.0001), and negatively associated with the LAV% (ρ = -0.262,
p = 0.007) (Fig 2). The SFA was negatively associated with the LAV% (ρ = -0.284, p = 0.007)
but was not related to the
p
Aaw at Pi10 (ρ = 0.169, p = 0.116) in the COPD patients. Table 4
shows the results of the univariate analyses elucidating the association of the clinical parame-
ters with the EAT area in the COPD patients. The EAT area was significantly correlated with
age, BMI, FEV1% predicted, and FEV1/FVC. An increase in the EAT area was also associated
with self-reported hypertension, self-reported CVD and statin use (data not shown). Multiple
regression analyses showed that the BMI, self-reported CVD and
p
Aaw at Pi10 were indepen-
dent predictors of the EAT area in the COPD patients (R2 = 0.51, p< 0.0001) (Table 5).
Coronary calcium score and adipose tissue in patients with CVD
Unlike the results for the EAT area, there was no significant difference in the CAC scores
between the two groups (Table 2). The EAT areas and CAC scores were higher in patients with
CVD in the present study (Fig 3), which is consistent with previous studies [6, 20]. Unlike the
results for the EAT area, the CAC score was not correlated with the other parameters for the
subjects, including age, BMI, pack-years, MRC dyspnea scale, pulmonary function tests,
p
Aaw
at Pi10, or LAV% (data not shown).
Comparison of data among CT-based phenotypes
We defined upper limits of “normal” for the CT measurements of LAV% and
p
Aaw at Pi10 as
the junction between the 3rd and 4th quartile for these measurements in the non-COPD smok-
ers. Based on these cut-offs, as previously reported [9], the COPD patients were divided into
four groups (Fig 4): 1) normal by CT (NCT; low LAV% and low
p
Aaw at Pi10), 2) airway-
dominant (AD; low LAV% and high
p
Aaw at Pi10), 3) emphysema-dominant (ED; high LAV
% and low
p
Aaw at Pi10) and 4) mixed (Mixed; high LAV% and high
p
Aaw at Pi10)
phenotypes.
The comparisons of the data among the phenotypes are summarized in Table 6. There were
no differences in age, pack-years, or MRC dyspnea scale among the four phenotypes. As
Table 3. Spearman’s rank correlation coefficients (ρ/p value) for LAV% and
p
Aaw at Pi10 in COPD patients.
LAV%
p
Aaw at Pi10
ρ p value ρ p value
Age (years) 0.077 0.434 0.338 <0.0001
BMI (kg/m2) -0.373 <0.0001 0.201 0.039
Pack-Years 0.265 0.006 -0.049 0.618
MRC dyspnea scale 0.272 0.006 0.160 0.107
FVC % predicted (%) -0.087 0.378 -0.137 0.163
FEV1 % predicted (%) -0.450 <0.0001 -0.149 0.129
FEV1/FVC (%) -0.565 <0.0001 -0.135 0.168
DLCO/VA (mL/min/mmHg/L) -0.626 <0.0001 -0.049 0.626p
Aaw at Pi10 (mm) -0.072 0.465 - -
BMI, body mass index; MRC, Medical Research Council; FVC, forced vital capacity; FEV1, forced expiratory volume in 1 s; DLCO, carbon monoxide
diffusing capacity; LAV%, percentage of low attenuation volume;
p
Aaw at Pi10, square root of airway wall area of a hypothetical airway with an internal
perimeter of 10 mm.
doi:10.1371/journal.pone.0148794.t003
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Fig 2. Correlation between adipose tissue and quantitative CT parameters in COPD patients. Spearman’s rank correlation coefficient was used to
evaluate these relationships. The EAT area was positively associated with the
p
Aaw at Pi10 (A) and inversely associated with the LAV% (B). The SFA was
inversely associated with the LAV% (D) but not with the
p
Aaw at Pi10 (C).
doi:10.1371/journal.pone.0148794.g002
Table 4. Spearman’s rank correlation coefficient (ρ/p value) for EAT area in COPD patients.
EAT area (cm2)
ρ p value
Age (years) 0.237 0.015
BMI (kg/m2) 0.600 <0.0001
Pack-Years 0.071 0.472
MRC dyspnea scale -0.047 0.634
FVC %predicted (%) 0.051 0.604
FEV1 %predicted (%) 0.197 0.044
FEV1/FVC (%) 0.234 0.016
DLCO / VA (mL/min/mmHg/L) 0.154 0.120
EAT, epicardial adipose tissue; BMI, body mass index; MRC, Medical Research Council; FVC, forced vital
capacity; FEV1, forced expiratory volume in 1 s; DLCO, carbon monoxide diffusing capacity.
doi:10.1371/journal.pone.0148794.t004
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previously reported, the BMI was significantly lower in the patients with the ED phenotype
compared with the AD phenotype [11].
As shown in Fig 5, the subjects with the AD and mixed phenotypes had greater EAT areas
than those with the NCT and ED phenotypes. Although there was no significant difference
between the patients with the AD and the mixed phenotypes, the EAT area tended to be higher
in those with the AD phenotype.
Vietnamese population
To confirm the above results, the relationships between the EAT area and the CT parameters
were investigated in an independent group of 225 Vietnamese COPD patients. The characteris-
tics of these patients are summarized in S1 Table. These subjects were younger and had lower
BMIs and smoking histories than the Japanese COPD patients. S2 Table shows the results of
the univariate analyses elucidating the associations of the clinical parameters with the EAT
areas in the Vietnamese COPD patients. The EAT area was significantly correlated with the
BMI, LAV% and
p
Aaw at Pi10. The multiple regression analyses showed that BMI and
p
Aaw
at Pi10 were independent predictors of the EAT area in the Vietnamese COPD patients (R2 =
0.29, p< 0.0001) (S3 Table). Additionally, when subjects were divided into four phenotypes
according to previous report [19], the EAT area in those with the AD phenotype was higher
than those with the other phenotypes (S4 Table). These results replicate those of the Japanese
COPD patients.
Table 5. Multiple regression analyses for predictors of EAT area.
Coefﬁcient Standard Error 95% Conﬁdence Interval p value
BMI (kg/m2) 1.23 0.15 0.93 to 1.54 <0.0001
Self-reported CVD (no vs yes) -2.64 0.60 -3.82 to -1.45 <0.0001p
Aaw at Pi10 (mm) 15.0 5.05 5.03 to 25.1 0.004
EAT, epicardial adipose tissue; BMI, body mass index; CVD, cardiovascular disease;
p
Aaw at Pi10, square root of airway wall area of the hypothetical
airway with an internal perimeter of 10 mm.
doi:10.1371/journal.pone.0148794.t005
Fig 3. Comparison of EAT area and CAC score between COPD patients with and without CVD. The EAT area (A) was measured using ImageJ software
Ver.1.47, and the CAC score (B) was evaluated using the Agatston method. The EAT areas and CAC scores were higher in the COPD patients (p < 0.001).
doi:10.1371/journal.pone.0148794.g003
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Discussion
In the present study, the subcutaneous fat mass and EAT were separately evaluated using a
chest CT, and the relationships of these variables with COPD phenotypes were determined.
Fig 4. Relationship between
p
Aaw at Pi10 and the LAV% in 105 COPD patients. The horizontal line shows the third quartile of the LAV% of the non-
COPD smokers. The vertical line shows the third quartile of the
p
Aaw at Pi10 of the non-COPD smokers. Using these cut-off values, the COPD patients can
be divided into 4 phenotypes; normal by CT (NCT; low LAV% and low
p
Aaw at Pi10), airway-dominant (AD; low LAV% and high
p
Aaw at Pi10),
emphysema-dominant (ED; high LAV% and low
p
Aaw at Pi10) and mixed (Mixed; high LAV% and high
p
Aaw at Pi10) phenotypes.
doi:10.1371/journal.pone.0148794.g004
Table 6. Classification by CT phenotypes in the COPD patients.
NCT (n = 16) AD (n = 16) ED (n = 43) Mixed (n = 30) p value
Age (years) 70.1 ± 6.62 74.3 ± 6.87 72.3 ± 8.39 75.4 ± 6.40 0.068
Male (%) 87.5 87.5 93.0 96.7 0.595
BMI (kg/m2) 23.3 ± 2.34 24.6 ± 2.27† 22.2 ± 2.60 23.4 ± 3.09 0.027
Pack-Years 50.3 ± 20.9 52.4 ± 27.7 65.2 ± 29.5 65.8 ± 38.6 0.273
MRC dyspnea scale* 1.50 ± 1.16 2.00 ± 1.26 1.74 ± 1.33 1.93 ± 1.11 0.575
FVC % predicted (%) 104.1 ± 13.1 94.0 ± 18.7 102.6 ± 17.3 100.8 ± 20.6 0.360
FEV1 % predicted (%) 78.3 ± 18.1 69.8 ± 17.4 65.2 ± 22.3 61.6 ± 25.1 0.066
FEV1/FVC (%) 59.8 ± 8.54†‡ 58.9 ± 8.86†‡ 50.0 ± 13.1 47.4 ± 13.3 0.001
DLCO / VA (mL/min/mmHg/L)* 3.19 ± 0.88†‡ 3.36 ± 0.81†‡ 2.37 ± 0.96 2.56 ± 0.91 0.002
The data are presented as the mean ± standard deviation or %.
BMI, body mass index; MRC, Medical Research Council; FVC, forced vital capacity; FEV1, forced expiratory volume in 1 s; DLCO, carbon monoxide
diffusing capacity.
† p<0.05 compared with the ED phenotype;
‡ p<0.05 compared with the Mixed phenotype
* n = 103
doi:10.1371/journal.pone.0148794.t006
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The epicardial fat accumulation was independently associated with the airway wall thickness in
the COPD patients. The EAT area was also associated with the frequency of self-reported
CVD. To our knowledge, no previous report has explored the relationship between the epicar-
dial fat area and the COPD phenotype using a chest CT.
EAT, one form of visceral adipose tissue (VAT), produces adipocytokines that play key
roles in the progression of atherosclerosis and CVD [21]. Furthermore, EAT may affect the
development of CVDmore than VAT because it deposits around the coronary arteries. In fact,
it has been reported that the CT-measured EAT volume showed a stronger correlation with
CVD than abdominal VAT in non-obese patients [22, 23].
Both the EAT and the subcutaneous fat mass were positively correlated with BMI. However,
only the EAT was positively correlated with the airway wall thickness. As we have previously
reported [11], the BMI was significantly lower in the patients with the ED phenotype. Indeed,
in Japanese COPD patients, emphysema is the most common phenotype; the ED and the
mixed phenotypes represent the majority of cases [24], Similarly, most of the patients in this
study were non-obese (Table 1), but the EAT correlated positively with the
p
Aaw at Pi10,
which suggests epicardial fat accumulation and airway remodeling may share a pathogenetic
mechanism. Further evidence that there may be a relationship between airway remodeling and
fat metabolism is provided by the fact that subjects with the mixed phenotype, despite having
worse lung function than the ED group, did not have a decreased BMI while the emphysema-
Fig 5. Association of EAT area with the CT phenotypes in COPD patients. TheWilcoxon Rank-Sum test was used to compare groups. The subjects with
the AD and Mixed phenotypes had greater EAT areas than those with the NCT and ED phenotypes.
doi:10.1371/journal.pone.0148794.g005
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dominant group did. This result supports our hypothesis that there is a relationship between
airway wall thickening and fat accumulation.
Emphysema represents parenchymal destruction, and airway remodeling represents accu-
mulation of extracellular matrix and mesenchymal cell proliferation in the airways, which is
observed as an increase in the airway wall thickness as measured by CT [9, 25]. Several reports
have found that there is an increased accumulation of fat in chronic inflammatory diseases,
including COPD [26–28]. Specifically, it is thought that chronic systemic inflammation con-
tributes to epicardial fat accumulation [8]. Several studies have found associations between
increased VAT and chronic inflammatory diseases, including psoriasis [28] and rheumatoid
arthritis [29], which suggests specific roles for VAT in inflammation. Two studies have
reported that deposition of excessive visceral fat mass was observed by CT in COPD patients
[26, 30]. Kishida et al. reported that abdominal visceral fat is more closely associated with the
risk factors for CVD than subcutaneous fat [31]. Moreover, increased visceral fat was positively
associated with serum IL-6 levels [30]. The reason why EAT is associated with airway wall
thickness is unclear. The systemic inflammation is thought to play an important role in the
mechanism. However, in this study, we did not measure inflammatory markers. Further stud-
ies are needed to clarify the relationship between increased airway wall thickening and epicar-
dial fat accumulation.
In this study, the EAT area was significantly increased in the COPD group (p = 0.038), which
is consistent with the previous research [8]. On the other hand, Kaplan and colleagues have
recently reported that epicardial fat in COPD patients with right ventricular systolic dysfunction
was lower than non-COPD subjects [32]. The reason for this discrepancy could be explained by
the difference of the subjects’ background. In this study, the GOLD spirometric classification of
the COPD patients was 33, 43 and 29 in GOLD 1, 2 and 3/4, respectively, and epicardial fat
accumulation was lower as lung function deteriorated (p = 0.076). However, Kaplan et.al. did
not mention spirometric data. Since none of the patient had any physical findings related with
acute or chronic heart failure, we did not carry out the echocardiography. We could not discuss
whether asymptomatic right ventricular systolic dysfunction was latent or not.
There was no significant difference in the CAC score between the two groups. Previous
reports have found a higher CAC score in COPD [33]. The reason for this discrepancy might
be that although the non-COPD smokers in this study had normal pulmonary function (FEV1/
FVC> 70%), they were not “healthy smokers.” Some of these patients had respiratory symp-
toms, and some were severely obese. Furthermore, there were no significant differences in the
prevalence of hypertension and DM between the two groups. Therefore, the CAC score could
be influenced more by these comorbidities, whereas the EAT area is related to the pathogenesis
of COPD. As previously reported [6, 20], both the EAT areas and the CAC scores were higher
in patients with CVD and were independent predictors of CVD in the present study, which
suggests that our methods were appropriate for measuring the EAT area and the CAC scores.
Interestingly, airway wall thickness was correlated with the EAT area but not with the CAC
score in the COPD patients. As discussed above, epicardial fat may influence chronic inflam-
mation in COPD and contribute to an increased risk for CVD, whereas the CAC may increase
the risk for CVD through a different mechanism. The CAC score is specific for the evaluation
of the calcification of coronary arteries, an early stage of CVD. These data suggest that COPD
and CVDmay share the same cause, chronic inflammation, but a direct relationship between
the airway wall thickness and coronary calcification may not exist.
We confirmed that the EAT area was related to the airway lesions in the Vietnamese popu-
lation, although the characteristics of the patients in these two groups were dissimilar. This
finding suggests that the results are not specific to the Japanese COPD population but are
applicable to other racial groups.
Epicardial Fat and Airway Lesion in COPD
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There are some limitations to this study. First, the sample size was relatively small. However,
the results from two independent populations were concordant, which increases confidence in
the findings. Large longitudinal studies are needed to confirm that the EAT is associated with
airway wall thickening in COPD patients. Second, the comorbidities were based on the declara-
tions of the patients and were not independently verified. There was no information about sleep
apnea syndrome and the subjects’ physical activity which could influence on fat accumulation.
Third, the non-COPD smokers who participated in this study were also from one pulmonary
clinic. The advantages were that the approaches and protocols for questionnaires, pulmonary
function tests, and CT scanning were standardized. However, as discussed above, our group of
non-COPD smokers may not represent so-called healthy smokers. Forth, although the measure-
ment of EAT using CT data without echocardiography has been established by Abbara et al
[34], we did not carry out the echocardiography to evaluate EAT in this study.
In conclusion, this is the first study to show that the amount of EAT is associated with air-
way wall thickening, a specific phenotype of COPD. The risk of CVD may be related to the CT
phenotypes in COPD patients.
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